Gyroscope Therapeutics Holdings

Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom.

LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics announces research collaboration agreement with Children's Medical Research Institute to develop novel gene therapy capsids.

Gyroscope Therapeutics Announces Research Collaboration Agreement with Children's Medical Research Institute to Develop Novel Gene Therapy Capsids

Five Star Bancorp

Anebulo Pharmaceuticals

Bowman Consulting Group

Honest Co

Maquia Capital Acquisition Corp

Onion Global Ltd

Talaris Therapeutics

Waterdrop

Eight IPOs and four SPACs went public this past week. The week's best performer, Sacramento bank Five Star Bancorp (FSBC) priced at the high end to raise $105 million at a $325 million market cap.

U.S. IPO Weekly Recap: Sacramento Bank Five Star Bancorp Finishes On Top In An 8 IPO Week

The news is also a blow to FTSE 250-listed Syncona, which recently upped its stake to 54%

News for Gyroscope Therapeutics Holdings Stock (VISN)